In humans, mutations in BMPR1A, SMAD4 and PTEN are responsible for juvenile polyposis syndrome 1 , juvenile intestinal polyposis 2 and Cowden disease 3 , respectively. The development of polyposis is a common feature of these diseases, suggesting that there is an association between BMP and PTEN pathways 4, 5 . The mechanistic link between BMP and PTEN pathways and the related etiology of juvenile polyposis is unresolved. Here we show that conditional inactivation of Bmpr1a in mice disturbs homeostasis of intestinal epithelial regeneration with an expansion of the stem and progenitor cell populations, eventually leading to intestinal polyposis resembling human juvenile polyposis syndrome. We show that BMP signaling suppresses Wnt signaling to ensure a balanced control of stem cell self-renewal. Mechanistically, PTEN, through phosphatidylinosital-3 kinase-Akt, mediates the convergence of the BMP and Wnt pathways on control of b-catenin. Thus, BMP signaling may control the duplication of intestinal stem cells, thereby preventing crypt fission and the subsequent increase in crypt number.
Wnt signaling through b-catenin promotes cell proliferation 6, 7 , and abnormal activation of b-catenin due to deregulated Wnt signaling leads to adenomatous polyposis coli in intestines 6, 7 . The BMP pathway also has a key role during gastrointestinal development 8, 9 and in maintaining tissue homeostasis in the adult 10 . According to current models, BMP2 and BMP4 function by binding to their type II receptor and recruiting type I receptors (Bmpr1a or Bmpr1b). The signal is transduced from the cytoplasm into the nucleus through Smad transcription factors 10 . Activity of BMP can be further regulated by its antagonist, Noggin (encoded by Nog) 11 . Mutations in the tumorsuppressor gene PTEN (a dual protein and lipid phosphatase) 12 have also been found in gastrointestinal cancers 13 . PTEN is a negative regulator of phosphatidylinosital-3 kinase (PI3K) 14 , which, through Akt (a serine-threonine kinase), promotes cell-cycle progression and suppresses apoptosis. Thus, PTEN inhibits Akt activity and the signals downstream of Akt 13 .
Intestinal stem cells (ISCs), identified using modified 5-bromodeoxyuridine (BrdU)-retaining assays 15 , are located at the fourth or fifth cell position from the base of each crypt in the small intestine, superior to Paneth cells (Fig. 1a-c) . Multipotent ISCs are responsible for generating the entire crypt-villus structure as shown by clonal assays 15, 16 . To investigate the role of BMP signaling in regulating intestinal development, we determined the expression patterns of BMP4, its antagonist Noggin, Bmpr1a and phosphorylated (P-) Smad1, P-Smad5 and P-Smad8 (Fig. 1d-k) . BMP4 was expressed in the intravillus and intercrypt mesenchymal cells, including those adjacent to ISCs (Fig. 1d,e) . Bmpr1a had a gradient distribution in epithelial cells along the crypt-villus axis and was also highly expressed in ISCs (Fig. 1f,g ) but not in the cells in the proliferating zone (Fig. 1f) . Noggin was expressed in the submucosal region adjacent to the crypt bottom and in only some cells in the ISC position or the surrounding cells (Fig. 1h,i) . The presence of active BMP signaling was reflected by the presence of P-Smad1, P-Smad5 and P-Smad8 in both villi and ISCs (Fig. 1j,k) . Noggin antagonizes BMP signaling to regulate the stem cell niche during neurogenesis 17 . We hypothesized that transient expression of Noggin (Fig. 1h,i ) may also function to control ISC properties through regulation of BMP activity.
Because the null mutation of Bmpr1a is lethal to the embryo 18 , we generated mice in which Bmpr1a can be conditionally inactivated using the interferon-inducible Mx1-cre line 19 . The efficiency of the Mx1-cre line in mediating loxP-dependent DNA excision in the intestine was determined using Z/EG reporter mice 20 . Expression of interferon in Mx1-cre mice was induced by injection of polyinosinicpolycytidylic acid (PolyI:C). Clonal expression of enhanced green fluorescent protein (EGFP) was detected in the entire crypt-villus of some units, consistent with previous reports 15, 16 . As each unit is generated from a single ISC, clonal expression of EGFP indicates that the PolyI:C-induced gene deletion occurred in the stem cells. In contrast, the cells emanating from ISCs that escape targeting retain LacZ expression (Fig. 2a,b) .
The 15 Bmpr1a mutant mice that we analyzed all developed multiple polyps (15-40 polyps in the segment located 15-25 cm from the pylorus; Fig. 2c,d) , and successful targeting of Bmpr1a was confirmed by loss of P-Smad1, P-Smad5 and P-Smad8 (Fig. 2e,f) . The polyps ranged from diminutively small and sessile (averaging 0.2 mm in diameter) to large and pedunculated (averaging 2 mm in diameter). Histopathological analyses of early-stage polyps in the intestinal tract showed general overgrowth of intestinal tissue with an increased number of crypts and fused villi. At later stages, the polyps developed into structures with cystically dilated and distorted glands, some filled with mucin and inflammatory cells with surrounding fibrous stroma (Fig. 2d) . These late-stage polyps had a histology similar to that seen in human juvenile polyposis syndrome 1 .
We observed severe gastrointestinal defects in the Bmpr1a mutant mice, which prompted us to determine how intestinal development is affected. In wild-type mice, proliferating cells were located in the upper crypt region where Bmpr1a is absent (compare Fig. 1f with Fig. 2g) , as identified by Ki67 presence. In Bmpr1a mutant mice, the proliferating cell population was expanded substantially, primarily owing to the increase in the number of crypts in the polyp region (Fig. 2h) . This result suggests that BMP signaling restricts crypt cell fate.
Wnt signaling normally favors crypt cell fate over villus differentiation 6, 7, 9 . The increased number of crypts suggested that Wnt signaling might be affected in the intestines of Bmpr1a mutant mice. We therefore compared Wnt signaling, as measured by the level of activated (phosphorylated) LRP6 (P-LRP6), in wild-type and Bmpr1a mutant mice. LRP6, a coreceptor for Wnt, becomes phosphorylated upon Wnt binding 21 and serves as a marker for active Wnt signaling. Wnt signaling was active in normal intestinal crypts ( Fig. 3a) and in the polyp crypts of Bmpr1a mutant mice (Fig. 3b) . We also measured the transcriptional activity of b-catenin by electroporating, into cultured intestinal segments, a reporter plasmid bearing TCF-b-catenin binding sites (Top) 22 driving a short-lived mutant of green fluorescent protein (GFP; Top-d2GFP). b-catenin transcriptional activity was detected primarily in the ISCs, despite the widespread presence of an active Wnt signal (as measured by P-LRP6) in the progenitor cells of crypts (Fig. 3c,d ). This observation led us to hypothesize that Wnt signaling is required for the nuclear activity of b-catenin but is not sufficient to fully activate b-catenin in ISCs, particularly when BMP signaling is active (Fig. 1k) .
Inactivation of PTEN has been reported to activate Akt and the subsequent nuclear accumulation of b-catenin 23 , suggesting that the PTEN-Akt pathway might regulate b-catenin activity in ISCs. We therefore analyzed both PTEN and the inactive (phosphorylated) form of PTEN (P-PTEN) 24 in intestines of wild-type mice and found that P-PTEN was present specifically in ISCs (Fig. 3e) . We detected P-PTEN in BrdU-retaining ISCs (Fig. 3f) , supporting this conclusion. We also detected phosphorylated Akt (P-Akt) in BrdU-retaining ISCs (Fig. 3g,h) , consistent with the role of PTEN as a negative regulator of Akt 14 . We then asked whether the PTENAkt pathway affects b-catenin activity in ISCs. We observed that b-catenin was associated with the membrane in quiescent ISCs (Fig. 3i) but was found in the nucleus of P-PTEN + ISCs (Fig. 3j) . This nuclear localization of b-catenin correlates with the activation of Top-d2GFP reporter plasmid in P-PTEN + ISCs (Fig. 3d) . We also found nuclearly localized b-catenin in dividing (BrdU-retaining) ISCs (Fig. 3k,l) . Furthermore, analysis of Top-GAL 25 transgenic mice showed that in vivo b-catenin signaling was active in ISCs, including those actively dividing ( Fig. 3m-o) . Taken together, these data support the idea that nuclearly localized b-catenin has a role in promoting ISC division. Thus, inactive PTEN (P-PTEN), through Akt, may coordinate with the Wnt signal to fully activate b-catenin in ISCs.
We next asked what signal controls PTEN activity. Genetic evidence suggests that there is an association between the BMP and PTEN pathways 4 , and the BMP signal has been shown to enhance PTEN activity 5 . Western-blot analysis showed that levels of P-PTEN and P-Akt were 4-5 times higher in three Bmpr1a mutant mice than in wild-type mice (Fig. 3p) , suggesting that BMP inhibits Akt activity through regulation of PTEN activity. We further examined the levels of P-PTEN and P-Akt in ISCs when BMP signaling is blocked. We detected only a single ISC in the ISC position in wild-type crypts (Fig. 3e-h ) but detected two side-by-side, aligned ISCs in a portion of the crypts in the polyp regions in Bmpr1a mutant mice, as identified by the presence of P-PTEN or P-Akt (Fig. 3q,r ; see below for ISC number quantification). This observation indicates that BMP signaling regulates the PTEN-Akt pathway in ISCs. We considered whether b-catenin activity changed correspondingly in Bmpr1a mutant mice. The presence of doublet cells showing nuclear localization of b-catenin (Fig. 3s) in the polyp region further supports the interpretation that nuclear accumulation of b-catenin in ISCs is inhibited by BMP signaling by regulating PTEN activity. We also observed crypt fission in the polyp region of Bmpr1a mutant mice (Fig. 3t) .
Therefore, a second signal must abrogate BMP and coordinate with Wnt to fully activate b-catenin in ISCs. To address this, we also analyzed the effect of Noggin on levels of P-PTEN and P-Akt and on the subcellular localization of b-catenin in ex vivo cultured intestine (Fig. 4a-l) . Treatment with Noggin increased the levels of P-PTEN and P-Akt and led to the relocation of b-catenin to the nucleus (Fig. 4c,g,k) , although western blotting showed that the total amount of b-catenin in cells did not change substantially ( Supplementary  Fig. 1 online) . A PI3K inhibitor, Ly294002, antagonized the effect of Noggin on nuclear relocalization of b-catenin (Fig. 4l) , arguing that this regulation is mediated through the PTEN-Akt pathway.
Further supporting the idea that BMP has a role in regulating b-catenin transcriptional activity through PTEN and Akt, exposure to Noggin or expression of dominant-negative Bmpr1a activated b-catenin activity, whereas expression of constitutively activated Bmpr1a or treatment with Ly294002 inhibited b-catenin activity as assayed by Top-Luc (luciferase) activity (Fig. 4m) . We also tested the direct regulation of b-catenin activity by Akt. Constitutively active Akt also enhanced b-catenin activity in a dosage-dependent manner (Fig. 4n) . These results provide further evidence supporting our hypothesis that b-catenin activity can be regulated by BMP signaling through Bmpr1a and the PI3K-Akt pathway.
BMP signaling may therefore have a role in inhibiting ISC selfrenewal by inhibiting b-catenin activity, thereby balancing the role of Wnt-b-catenin in promoting stem cell self-renewal 26 . If this hypothesis is correct, then we would anticipate an increase in the self-renewal capacity of ISCs when the BMP signal is blocked. We therefore examined the stem cell zone in multiple crypts of the polyp regions in Bmpr1a mutant mice. We compared the number of ISCs in equal lengths (670 mm) of intestinal sections from nine normal regions of three wild-type mice and five polyp regions of three Bmpr1a mutant mice ( Table 1) ; ISCs were recognized by P-PTEN. We found that, on average, there were B3.1 times more crypts in polyp regions (47 7 3.8 crypts; mean 7 s.d.) than in normal regions (14.8 7 1.1 crypts; mean 7 s.d.) of intestines of Bmpr1a mutant mice. This increase in crypt number was accompanied by a B1.6-fold increase in the number of ISCs per crypt. This resulted in a B5-fold increase in the average number of ISCs in Bmpr1a mutant mice compared with wild-type mice. Taken together, these results suggest that BMP signaling has a role in inhibiting ISC self-renewal by regulating PTEN activity, consistent with previous reports that inactivation of PTEN leads to activation of PI3K-Akt and results in expansion of embryonic and neural stem cell populations 27, 28 .
BMP signaling was recently reported to repress crypt formation and polyp growth in Nog transgenic mice by inhibiting Wnt signaling 9 . Using a Bmpr1a mutant model, we obtained similar findings and further explored the underlying mechanisms. We are not excluding the possibility that inactivation of Bmpr1a affects the canonical BMP-Smad pathway, which may control expression of Wnt or Frizzled proteins and may also regulate epithelial differentiation and apoptosis. That pathway may, in part, contribute to the development of polyposis (as mutations in SMAD4 also lead to polyp formation) 2 . But our data clearly show that PTEN, through PI3K-Akt, mediates the convergence of the BMP and Wnt pathways on control of b-catenin activity, thereby ensuring a balanced control of ISC self-renewal (Supplementary Fig. 2 online) . Wnt signaling, as detected by P-LRP6, is active not only in stem cells but in all the proliferating cells. We also found that nuclearly localized b-catenin and the underlying transcriptional activity of b-catenin are primarily associated with P-PTEN in ISCs. These observations suggest that Wnt signaling is required for stem cell activation and self-renewal but is not sufficient. A second signal is therefore required for stem cell activation. We propose that this second signal is dependent on the transient expression of Noggin and is required to override the BMP signal, releasing the inhibition of b-catenin by PTEN and thus coordinating with Wnt signaling to activate stem cells ( Supplementary Fig. 2 online) . Supporting this idea, the Noggin-Wnt coordination has also been reported to be required for initiation of the hair growth cycle 29 . Finally, it has been proposed that crypt fission (duplication) is triggered by stem cell duplication 30 . In this study, we document the correlation between stem cell duplication (Fig. 3q-s) and crypt number increase, suggesting that BMP signaling may control crypt fission ( Fig. 3t) through inhibition of stem cell self-renewal and their subsequent duplication.
METHODS
Inducible Cre expression. We injected mice intraperitoneally with PolyI:C (250 mg per mouse) on days 21, 23 and 25. Four to six months after injection, we found polyps in the small intestines, from the jejunum to the ileum (15-25 cm measured from the pylorus). The animal protocol used in these studies was approved by the Institutional Animal Care and Use Committee at Stowers Institute.
Intestinal specimen preparation and immunohistochemical staining. We collected specimens from the small intestines (segments 15-25 cm below the pylorus) of mutant and wild-type mice. We prepared specimens and carried out immunochemical and immunofluorescent stainings following standard procedures (Supplementary Methods online). We carried out X-gal staining for detection of lacZ expression as described 20 .
BrdU retaining assay 15 . We irradiated C57B6/L and BMP4-lacZ mice (aged 6-8 weeks; 15 . We carried out BrdU in situ staining using a staining kit (Zymed Laboratories). We collected BrdU data on day 22.
Ex vivo culture. We carried out intestinal culture in 50% DMEM-1 medium without calcium (Biosource), 40% supplemented F-12/ Mixture (Biosource), 10% fetal bovine serum, 1% Pen-Strep and 1% Fungizone plus 50 mM Ly294002 (Sigma) and 25 ng ml À1 of Noggin or BMP4 (R&D system) as indicated. We soaked AffyGel blue beads (100-200 mesh, BioRad) in 500 mg ml À1 of Noggin or BMP4 and then injected them into 0.5-inch intestinal segments (10 beads per segment). We introduced DNA by electroporation (Square Electroporator CUY-21, BEX). We injected 100 mg of Topd2GFP (Sin-18.ppt.ot-EGFP) into 0.5-inch intestinal segments submerged in phosphate-buffered saline and applied five pulses (20 V and 50 ms).
Transfection assay. We transfected IEC18 cells using Lipofectamine (Invitrogen) with 1 mg of Top-Luc, 1 mg of Fop-Luc (Upstate) or 0.1 mg of TK-LPR (internal control; Invitrogen) and plasmids as indicated. Twelve hours after transfection, we treated the cells with Noggin and Ly294002 separately or in combinations for another 8 h. We then collected cells for luciferase assays (Dual-Luciferase Reporter Assay System; Promega, E1910).
Western-blot analysis. We homogenized intestinal tissue in a cocktail of 1 ml lysis buffer (100 mM Tris-HCl (pH 6.8), 2% SDS and a proteinase inhibitor cocktail supplied by Roche). The supernatant was collected after centrifugation. We fractionated protein extracts (25 mg per well) on SDS-PAGE gels and transferred them onto nitrocellulose membrane. The membrane was blocked using casein blocker (Pierce) and incubated with the appropriate dilutions of primary and secondary antibodies in casein blocker. We developed the membrane after washing it with TBST solution (Tris-buffered saline plus 0.05% Tween-20) and chemiluminescent reagents (Santa Cruz).
Note: Supplementary information is available on the Nature Genetics website.
